Serum insulin concentrations have been used as two methods were highly correlated (r=0. 97, p<0.0001), and the relationships among serum markers of insulin resistance in population studies examining the relationship between insulin resistinsulin concentrations, insulin sensitivity and blood pressure were independent of assay method; for ance and blood pressure, but the relationship is variable among studies. We hypothesized that differexample, in non-diabetic subjects the univariate correlation between log 10 AUC insulin and insulin sensitences in cross-reactivity of insulin assays with proinsulin and its split/des-amino products might account ivity index was similar with both methods [r=-0.81 vs. r=-0.82, p<0.0001 (specific vs. conventional for the variation. We therefore examined fasting and post-glucose load serum insulin concentrations assay)]. Discrepancies between studies in the relationship between serum insulin concentrations and (determined by both specific and conventional assays), insulin sensitivity (measured by the euglycablood pressure are unlikely to be due to crossreactivity of conventional insulin assays with emic clamp technique), and blood pressure, in a group of 56 diabetic (NIDDM) and non-diabetic proinsulin-like molecules. subjects. Insulin concentrations as measured by the
Introduction
Resistance to insulin-mediated glucose uptake is a resistance in the pathogenesis of essential hypertension.8-12 However, the relationship between insulin feature of non-insulin-dependent diabetes mellitus (NIDDM), obesity, essential hypertension and coronconcentrations and blood pressure is variable among studies and ethnic groups, particularly after adjustary heart disease.1,2 In non-diabetic obese and hypertensive individuals, normal glucose tolerance is ment for confounding variables such as body mass index (BMI), and its existence and significance maintained, at least in the short term, by increased pancreatic b-cell secretion of insulin. Serum insulin remain controversial.13-17 Commercially-available radioimmunoassays for concentrations in such individuals are raised in proportion to the degree of insulin resistance, and insulin cross-react with intact proinsulin and its partially-processed split and des-amino products. the resulting hyperinsulinaemia has been implicated in the pathogenesis of cardiovascular disease.1, [3] [4] [5] [6] However, sensitive and specific assays have now been developed for insulin and its precursor horBlood pressure appears to be more closely related to insulin sensitivity than to serum insulin concentramones.18-20 While partially-processed proinsulin products have decreased biological activity in terms tions,7 but measurement of insulin sensitivity is relatively labour-intensive, and circulating insulin of glucose disposal when compared with insulin, they have longer half-lives, and are not converted to concentrations (fasting and post-glucose load) have been used as surrogate measurements in many of insulin in the circulation. 21 It has been reported that serum concentrations of proinsulin-like molecules the large-scale studies which have implicated insulin are more strongly related than serum insulin concenthe other obese hypertensive. All attended an initial trations to cardiovascular risk factors in both nonscreening visit, when baseline characteristics were diabetic22,23 and NIDDM24 populations, and adults recorded, followed by two further study days. On who were of low birth weight appear to have the first of these, a standard 75 g oral glucose abnormal proinsulin processing. 25 It is possible that tolerance test (OGTT) was performed, with venous the cardiovascular risk attributed to insulin resistance blood samples being withdrawn from an indwelling and hyperinsulinaemia might in part reflect cross-21G venous cannula at 0, 30, 60, 90, and 120 min reactivity of proinsulin-like molecules in convenfor glucose and insulin measurements (all timetional insulin assays. points), and fasting cholesterol and triglycerides This study was designed to clarify, for the first (baseline sample only). On the second day, a moditime, whether the relationships among insulin confied (3 h) hyperinsulinaemic euglycaemic clamp was centrations, insulin sensitivity (measured using the performed (5.2 mmol/l):27 a primed infusion of sol-'gold standard' euglycaemic clamp technique26), and uble human insulin (1.5 mU/kg/min; Actrapid, blood pressure are affected by the specificity of the NovoNordisk) along with a variable rate infusion of assay used to determine serum insulin concentrations 20% dextrose (Baxter Healthcare) was administered and hence whether some of the variability between via a left antecubital vein for 3 h. The right hand studies in the relationship between insulin concentrawas placed in a heated-air hand box at 55°C tions and blood pressure might be accounted for by (University of Nottingham, Department of Physiology use of insulin assays with different degrees of crossand Pharmacology), and the dextrose infusion rate reactivity with proinsulin and its split/des-amino was adjusted on the basis of glucose concentrations products. measured in arterialized venous blood samples at the bedside. In the patients with NIDDM, serum glucose concentrations were gradually normalized with an infusion of soluble insulin (2 U/h) prior to Methods commencing the procedure. Fifty-six Caucasian subjects (49 male, 7 female;
Insulin sensitivity index was defined as: 
Laboratory methods
and those who gave a history of alcohol intake >20 units weekly. All had a serum creatinine within the Glucose concentrations were measured using the laboratory reference range. For the purposes of the glucose oxidase method (Beckman 2 glucose anastudy, body mass index of <30 kg/m2 was classified lyser, Beckman Instruments; inter-assay coefficient of as 'non-obese'; otherwise patients were deemed variation 1.5%). Serum insulin concentrations were 'obese'. Hypertension was defined as a mean supine determined by a commercially available assay highly diastolic BP of ≥95 mmHg or systolic BP specific for insulin (Lifescreen, Insulin EASIA; inter-≥160 mmHg on three readings after 10 min supine assay CVs 6.7% at 4.2 mU/l, 3.5% at 9.8 mU/l, and rest (Dinamap Critikon) on at least two separate 3.3% at 81 mU/l; intra-assay CV was lower than occasions. Diabetes was confirmed by OGTT accordthis) and also by a conventional assay with a ing to WHO criteria (75 g). Hypertensive subjects 62% molar cross-reaction with intact proinsulin were either newly diagnosed or withdrawn from all (Pharmacia insulin RIA 100; inter-assay CVs 5.8% at antihypertensive medication at least 4 weeks prior 11.6 mU/l, 6.4% at 32.7 mU/l, and 6.5% at 65.2 to the study; none had been taking thiazide diuretics mU/l). in the previous 6 months. Patients treated with insulin or oral hypoglycaemic agents were excluded.
The study design was such that patients and
Statistical analysis
controls were studied concurrently: for each nonAll data were checked for normality using the obese hypertensive subject recruited (NIDDM or Shapiro-Wilks test (Minitab statistical package), and non-diabetic), two age-and sex-matched controls were identified: one non-obese normotensive and logarithmic transformation (log 10 ) was performed where necessary. Area-under-the-curve (AUC) insulin concentrations. This analysis was performed separately for both specific and conventional assays. was calculated as a summary measure for each individual.29 A Bland-Altman plot of insulin concentrations as measured by the two assays was Results performed. Log 10 serum insulin and glucose concentrations were back-transformed to give the geometric All 56 subjects completed the protocol without mean for presentation of oral glucose tolerance test complication. Six of the non-diabetic subjects data. One-way ANOVA was used in the analyses of screened (one non-obese normotensive, one nonsteady state serum insulin concentrations and insulin obese hypertensive, and four obese hypertensive) sensitivity index by subgroup. Unpaired t-tests were were found on the basis of their post-load glucose used for comparisons between subgroups: in order concentrations to have impaired glucose tolerance to adjust for multiple comparisons, statistical signific-(IGT). The former two subjects were excluded from ance was assessed using 97.5% CIs (2p<0.05).
the study. Satisfactory matching was achieved In univariate analyses, simple correlations were (Table 1) between comparable subgroups for age, plotted of the relationships among serum insulin sex, and BMI, although within the NIDDM subjects concentrations, insulin sensitivity, and blood pressure the non-obese normotensive and obese hypertensive for the specific and conventional assays. To examine subgroups were younger than the non-obese hyperthe best predictors of insulin sensitivity index, multensive subgroup. tiple regression analysis was performed using the following predictor variables: age, sex, fasting and Simple assay comparison post-load glucose concentrations, systolic and diastolic blood pressure, BMI, waist-to-hip ratio, smokInsulin concentrations as measured by the two methods were highly correlated (r=0.97, ing status, and fasting cholesterol and triglyceride p<0.0001, Figure 1a) . A Bland-Altman plot revealed ever, these trends did not reach statistical significance (Figure 2 ). that AUC insulin concentrations by the conventional method were greater than or equal to those by the Glucose profiles specific method in 52 of the 56 subjects (Figure 1b) . For the non-diabetic subjects, the percentage There were no statistically significant differences in (mean±SD) of immunoreactive insulin which was fasting glucose concentrations within the nonaccounted for by specific insulin was 89±11.6, diabetic and NIDDM groups (Table 1) . However, 90±8.8, and 92±5.5% in the non-obese normowithin the non-diabetic group, AUC glucose was tensive, non-obese hypertensive, and obese hyperhigher in obese hypertensive compared with nontensive subgroups, respectively. For those with obese hypertensive subjects (2p<0.05), and in NIDDM, the equivalent percentages were 84±15.8, non-obese hypertensive compared with non-obese 87±15.3, and 88±7.4%. The largest differences normotensive subjects (2p<0.05, Figure 2 ). detected were in the obese NIDDM subjects and in obese non-diabetic subjects who were glucose intolInsulin sensitivity erant (Figure 1b) . In the four subjects in whom specific insulin concentrations were apparently Mean±SD steady-state insulin concentrations greater than conventional insulin concentrations, the (mU/ml) achieved during the euglycaemic clamp magnitude of the difference was small, and reflected procedures (exogenous insulin infusion) were higher a difference at a single time-point in the later part in obese subjects [non-diabetic subjects 113±20.6 of the OGTT.
(non-obese normotensive), 115±27.2 (non-obese hypertensive), 163±38.0 (obese hypertensive); NIDDM subjects 109±19.0 (non-obese normotens-
Insulin and glucose concentrations
ive), 121±27.9 (non-obese hypertensive), and
Insulin
159±60.6 (obese hypertensive)], p<0.01, ANOVA. The insulin sensitivity index (S IP ), correcting for Fasting and AUC insulin results were similar for both specific and conventional assays (Figure 2 ). In the steady-state insulin concentration, was therefore calculated for each subject (Figure 3) . Coefficients of non-diabetic subjects, AUC insulin was greater in obese hypertensive compared with non-obese hypervariation of blood glucose during the final 40 min of the clamps were 3.3% (non-diabetic subjects) and tensive subjects (2p<0.05, Figure 2) ; there was a tendency for AUC insulin to be greater in non-obese 4.7% (NIDDM subjects).
In both the non-diabetic subjects and subjects hypertensive compared with non-obese normotensive subjects, but this did not reach statistical significwith NIDDM, insulin sensitivity index ( Figure 3 ) was lower in the sub-groups with higher blood pressure ance (2p=0.14, Figure 2) . In NIDDM subjects, there was a trend for AUC insulin to be greater in obese and increased weight (non-diabetic subjects, p<0.001; NIDDM subjects p<0.01, ANOVA). hypertensive compared with non-obese hypertensive subjects, whom in turn tended to have higher AUC When subgroups were compared, with adjustment for multiple comparisons, insulin sensitivity index insulin than non-obese normotensive subjects; how- Figure 1 . Assay comparison. a Simple correlation. Log 10 AUC insulin from OGTT data in all subjects (n=53, missing data in 3 cases) determined using conventional and specific assays. b Bland-Altman plot. The difference between AUC insulin as measured by the conventional and specific assays plotted against log 10 specific AUC insulin. independent of assay specificity in both non-diabetic subjects and subjects with NIDDM ( 
Fasting insulin in non-diabetic subjects
There was a negative correlation ( Figure 4) 
Fasting insulin in subjects with NIDDM
There was a negative correlation (Figure 4 ) between log 10 fasting serum insulin and insulin sensitivity index: r=-0.47, p<0.05, 95% CI -0.12, -0.71 log 10 AUC insulin and insulin sensitivity: r=-0.81, p<0.0001, 95% CI -0.62, -0.91 (specific assay), was lower in obese than non-obese hypertensive r=-0.82, p<0.0001, 95% CI -0.64, -0.91 (convensubjects (non-diabetic subjects, 2p<0.05; NIDDM tional assay). subjects, 2p<0.01).
AUC insulin in NIDDM subjects

Insulin concentrations and insulin
There was no significant relationship between log 10 sensitivity AUC insulin and insulin sensitivity index: r=-0.24, 95% CI +0.17, -0.58 (specific assay), r=-0.33, The univariate relationships between insulin sensitivity index and serum insulin concentrations were 95% CI +0.07, -0.64 (conventional assay). 
Blood pressure and insulin sensitivity Predictors of insulin sensitivity
The results of multiple regression analyses were
Non-diabetic subjects almost identical when insulin concentrations Diastolic blood pressure was negatively correlated measured by either assay method were entered as with insulin sensitivity index ( Figure 6 ): r=-0.40, predictor variables. p< 0.05, 95% CI -0.05, -0.66.
Non-diabetic subjects NIDDM subjects
The best single predictor of insulin sensitivity index Diastolic blood pressure was negatively correlated was AUC insulin (adjusted R 2 =65%, p< 0.001);
with insulin sensitivity index ( Figure 6 ): r=-0.51, the best two combined predictors were AUC insulin p< 0.01, 95% CI -0.15, -0.75. and waist-to-hip ratio together (adjusted R 2 =80%, p< 0.001).
Insulin concentrations and blood pressure
NIDDM subjects Non-diabetic subjects BMI was the best predictor of insulin sensitivity index There was a positive correlation between log 10 AUC (adjusted R2 46%, p< 0.001). insulin and diastolic blood pressure, independent of assay method (Figure 7 ): r=0.40, p< 0.05, 95% CI 0.03, 0.68 (specific assay); r=0.38, p< 0.05, 95% Discussion CI 0, 0.66 (conventional assay).
The major finding of this study was that, in the NIDDM subjects subjects studied, the specificity of the insulin assay used to measure serum insulin concentrations had No significant relationship was detected with either no detectable effect on the relationships observed assay (Figure 7 ): r=0.24, p=0.18, 95% CI -0.17, amongst serum insulin concentrations, insulin sensit-0.58 (specific assay), r=0.28, p=0.17, 95% CI ivity, and blood pressure. Serum insulin concentra--0.13, 0.60 (conventional assay). tions measured by specific and conventional assays were highly correlated, and the relationships among non-obese, obese, and hypertensive NIDDM and non-diabetic subgroups in terms of serum insulin concentrations were almost identical, irrespective of the assay method used. The present study is the first, to our knowledge, to examine the relationships among serum insulin concentrations as measured by both conventional and specific insulin assay methods, euglycaemic-clamp derived insulin sensitivity, and blood pressure. Many of the large-scale studies which have examined the relationship between insulin concentrations and blood pressure in non-diabetic subjects measured insulin using conventional radioimmunoassays with a high degree of cross-reactivity with proinsulin and its partially-processed intermediates.8-12 Three of these studies used the same commercially available conventional assay kit (Pharmacia RIA 100) that was used in this study (62% molar cross-reaction with intact proinsulin).9,11,12 In contrast, there are few published data on the relationship between specific insulin concentrations and blood pressure. inconsistent relationships between insulin concentra- tions and blood pressure.31 This data, taken together confounding drug treatment. In non-diabetic subjects, the relationship between serum insulin concentrawith observations of adverse events during the clinical use of proinsulin21 and the associations between tions (as determined by either assay method) and blood pressure was almost identical to that between serum concentrations of proinsulin-like molecules and both birth weight25 and angiographic severity of euglycaemic clamp-derived insulin sensitivity and blood pressure. Taken with the findings from the San coronary atherosclerosis,32 led us previously to speculate that cross-reacting proinsulin-like molecAntonio group,35 our data suggest that assay specificity is unlikely to account for discrepancies between ules (rather than insulin itself ) might play a role in the pathogenesis of insulin resistance and/or hyperepidemiological studies in the strength of the relationship observed between serum insulin concentrations tension/atherosclerosis.33 Since that time, two further large epidemiological studies using specific insulin and blood pressure. It is likely that such discrepancies are accounted for either by differences in the assays have been reported. One of these, suggested that specific insulin concentrations were more highly populations studied,16 or by lack of standardization of insulin assays between centres. 36 We did not correlated with blood pressure in a general population than were those measured using a conventional measure proinsulin and partially-processed proinsulin products in the present study, but the relationships assay.34 The other, conducted in non-diabetic subjects from the San Antonio study, found no difference examined were almost identical when insulin concentrations were measured with insulin assays of in the relationship; however, confidence in this finding was diminished somewhat by the finding of both relatively high and no cross-reactivity with these molecules. Disproportionately elevated insulin conhigher insulin concentrations with the specific than with the conventional assay. 35 centrations measured with the conventional as opposed to specific insulin assay, suggesting high The detailed nature of the present study was such that only a relatively small number of subjects (n= levels of proinsulin-like molecules, were observed mainly in obese (NIDDM or non-diabetic glucose 56) could be studied. Insulin sensitivity was measured by a 3-h euglycaemic clamp technique, which is intolerant) subjects. However, this does not explain the lack of a univariate relationship between serum the acknowledged current 'gold standard,26 and the patients studied were not taking potentiallyinsulin concentrations and blood pressure in these disease mortality in a middle-aged population. Diabetologia subjects, as similar correlation coefficients and con- 
